Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1011

1.

Accelerating structure-function mapping using the ViVa webtool to mine natural variation.

Hamm MO, Moss BL, Leydon AR, Gala HP, Lanctot A, Ramos R, Klaeser H, Lemmex AC, Zahler ML, Nemhauser JL, Wright RC.

Plant Direct. 2019 Jul 26;3(7):e00147. doi: 10.1002/pld3.147. eCollection 2019 Jul.

2.

Electron Accumulation Induces Efficiency Bottleneck for Hydrogen Production in Carbon Nitride Photocatalysts.

Yang W, Godin R, Kasap H, Moss B, Dong Y, Hillman SAJ, Steier L, Reisner E, Durrant JR.

J Am Chem Soc. 2019 Jul 17;141(28):11219-11229. doi: 10.1021/jacs.9b04556. Epub 2019 Jul 2.

PMID:
31265274
3.

Process evaluation of specialist nurse implementation of a soft opt-out organ donation system in Wales.

Noyes J, Mclaughlin L, Morgan K, Roberts A, Moss B, Stephens M, Walton P.

BMC Health Serv Res. 2019 Jun 24;19(1):414. doi: 10.1186/s12913-019-4266-z.

4.

SPI-1 is a missing host-range factor required for replication of the attenuated modified vaccinia Ankara (MVA) vaccine vector in human cells.

Liu R, Mendez-Rios JD, Peng C, Xiao W, Weisberg AS, Wyatt LS, Moss B.

PLoS Pathog. 2019 May 30;15(5):e1007710. doi: 10.1371/journal.ppat.1007710. eCollection 2019 May.

5.

The emergence of follow-on disease-modifying therapies for multiple sclerosis.

Moss BP, Cohen JA.

Mult Scler. 2019 May 10:1352458519845106. doi: 10.1177/1352458519845106. [Epub ahead of print]

PMID:
31074707
6.

Designing a co-productive study to overcome known methodological challenges in organ donation research with bereaved family members.

Noyes J, Mclaughlin L, Morgan K, Roberts A, Stephens M, Bourne J, Houlston M, Houlston J, Thomas S, Rhys RG, Moss B, Duncalf S, Lee D, Curtis R, Madden S, Walton P.

Health Expect. 2019 May 6. doi: 10.1111/hex.12894. [Epub ahead of print]

PMID:
31058410
7.

Rectal adenocarcinoma with rectoprostatic fistula following prostate brachytherapy.

Moss BF, Peracha AM.

BMJ Case Rep. 2019 Mar 31;12(3). pii: e226151. doi: 10.1136/bcr-2018-226151.

PMID:
30936326
8.

HIV-1 vaccination by needle-free oral injection induces strong mucosal immunity and protects against SHIV challenge.

Jones AT, Shen X, Walter KL, LaBranche CC, Wyatt LS, Tomaras GD, Montefiori DC, Moss B, Barouch DH, Clements JD, Kozlowski PA, Varadarajan R, Amara RR.

Nat Commun. 2019 Feb 18;10(1):798. doi: 10.1038/s41467-019-08739-4.

9.

The Effect of Materials Architecture in TiO2 /MOF Composites on CO2 Photoreduction and Charge Transfer.

Crake A, Christoforidis KC, Gregg A, Moss B, Kafizas A, Petit C.

Small. 2019 Mar;15(11):e1805473. doi: 10.1002/smll.201805473. Epub 2019 Feb 4.

PMID:
30716205
10.

Adjustment with aphasia after stroke: study protocol for a pilot feasibility randomised controlled trial for SUpporting wellbeing through PEeR Befriending (SUPERB).

Hilari K, Behn N, Marshall J, Simpson A, Thomas S, Northcott S, Flood C, McVicker S, Jofre-Bonet M, Moss B, James K, Goldsmith K.

Pilot Feasibility Stud. 2019 Jan 22;5:14. doi: 10.1186/s40814-019-0397-6. eCollection 2019.

11.

The efficacy of 'static' training interventions for improving indices of cardiorespiratory fitness in premenopausal females.

Herrod PJJ, Blackwell JEM, Moss BF, Gates A, Atherton PJ, Lund JN, Williams JP, Phillips BE.

Eur J Appl Physiol. 2019 Mar;119(3):645-652. doi: 10.1007/s00421-018-4054-1. Epub 2018 Dec 27.

12.

Novel Modified Vaccinia Virus Ankara Vector Expressing Anti-apoptotic Gene B13R Delays Apoptosis and Enhances Humoral Responses.

Chea LS, Wyatt LS, Gangadhara S, Moss B, Amara RR.

J Virol. 2019 Feb 19;93(5). pii: e01648-18. doi: 10.1128/JVI.01648-18. Print 2019 Mar 1.

PMID:
30541829
13.

The Predictive Ability of Pre-Operative Magnetic Resonance Imaging to Detect Pathological Outcomes in Prostate Cancer

Nason GJ, Selvarajah L, O’Connor EM, O’Kelly J, Considine SW, Moss B, MacMahon D, Heneghan J, Meyer N, Buckley J, O’Regan K, O’Brien MF.

Ir Med J. 2018 Aug 13;111(7):790.

PMID:
30520617
14.

The 2.1 Å structure of protein F9 and its comparison to L1, two components of the conserved poxvirus entry-fusion complex.

Diesterbeck US, Gittis AG, Garboczi DN, Moss B.

Sci Rep. 2018 Nov 14;8(1):16807. doi: 10.1038/s41598-018-34244-7.

15.

A remarkable insight into the cancer journey of Barbara Moss.

Moss B.

Future Oncol. 2019 Jan;15(1):5-12. doi: 10.2217/fon-2018-0681. Epub 2018 Oct 19.

16.

Human Host Range Restriction of the Vaccinia Virus C7/K1 Double Deletion Mutant Is Mediated by an Atypical Mode of Translation Inhibition.

Sivan G, Glushakow-Smith SG, Katsafanas GC, Americo JL, Moss B.

J Virol. 2018 Nov 12;92(23). pii: e01329-18. doi: 10.1128/JVI.01329-18. Print 2018 Dec 1.

17.

RNA Polymerase Mutations Selected during Experimental Evolution Enhance Replication of a Hybrid Vaccinia Virus with an Intermediate Transcription Factor Subunit Replaced by the Myxoma Virus Ortholog.

Stuart CA, Zhivkoplias EK, Senkevich TG, Wyatt LS, Moss B.

J Virol. 2018 Sep 26;92(20). pii: e01089-18. doi: 10.1128/JVI.01089-18. Print 2018 Oct 15.

18.

Origin of the poxviral membrane: A 50-year-old riddle.

Moss B.

PLoS Pathog. 2018 Jun 21;14(6):e1007002. doi: 10.1371/journal.ppat.1007002. eCollection 2018 Jun. Review. No abstract available.

19.

DNA Vaccine-Induced Long-Lasting Cytotoxic T Cells Targeting Conserved Elements of Human Immunodeficiency Virus Gag Are Boosted Upon DNA or Recombinant Modified Vaccinia Ankara Vaccination.

Hu X, Valentin A, Cai Y, Dayton F, Rosati M, Ramírez-Salazar EG, Kulkarni V, Broderick KE, Sardesai NY, Wyatt LS, Earl PL, Moss B, Mullins JI, Pavlakis GN, Felber BK.

Hum Gene Ther. 2018 Sep;29(9):1029-1043. doi: 10.1089/hum.2018.065. Epub 2018 Jun 21.

20.

First-in-Human Randomized, Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector.

Baden LR, Walsh SR, Seaman MS, Cohen YZ, Johnson JA, Licona JH, Filter RD, Kleinjan JA, Gothing JA, Jennings J, Peter L, Nkolola J, Abbink P, Borducchi EN, Kirilova M, Stephenson KE, Pegu P, Eller MA, Trinh HV, Rao M, Ake JA, Sarnecki M, Nijs S, Callewaert K, Schuitemaker H, Hendriks J, Pau MG, Tomaka F, Korber BT, Alter G, Dolin R, Earl PL, Moss B, Michael NL, Robb ML, Barouch DH; IPCAVD006/RV380/HIV-V-A002 Study Group .

J Infect Dis. 2018 Jul 13;218(4):633-644. doi: 10.1093/infdis/jiy212.

21.

Vaccinia Virus C9 Ankyrin Repeat/F-Box Protein Is a Newly Identified Antagonist of the Type I Interferon-Induced Antiviral State.

Liu R, Moss B.

J Virol. 2018 Apr 13;92(9). pii: e00053-18. doi: 10.1128/JVI.00053-18. Print 2018 May 1.

22.

Identification of Poxvirus Genome Uncoating and DNA Replication Factors with Mutually Redundant Roles.

Liu B, Panda D, Mendez-Rios JD, Ganesan S, Wyatt LS, Moss B.

J Virol. 2018 Mar 14;92(7). pii: e02152-17. doi: 10.1128/JVI.02152-17. Print 2018 Apr 1.

23.

Vaccination with Combination DNA and Virus-Like Particles Enhances Humoral and Cellular Immune Responses upon Boost with Recombinant Modified Vaccinia Virus Ankara Expressing Human Immunodeficiency Virus Envelope Proteins.

Gangadhara S, Kwon YM, Jeeva S, Quan FS, Wang B, Moss B, Compans RW, Amara RR, Jabbar MA, Kang SM.

Vaccines (Basel). 2017 Dec 19;5(4). pii: E52. doi: 10.3390/vaccines5040052.

24.

A Trimeric HIV-1 Envelope gp120 Immunogen Induces Potent and Broad Anti-V1V2 Loop Antibodies against HIV-1 in Rabbits and Rhesus Macaques.

Jones AT, Chamcha V, Kesavardhana S, Shen X, Beaumont D, Das R, Wyatt LS, LaBranche CC, Stanfield-Oakley S, Ferrari G, Montefiori DC, Moss B, Tomaras GD, Varadarajan R, Amara RR.

J Virol. 2018 Feb 12;92(5). pii: e01796-17. doi: 10.1128/JVI.01796-17. Print 2018 Mar 1.

25.

Enigmatic origin of the poxvirus membrane from the endoplasmic reticulum shown by 3D imaging of vaccinia virus assembly mutants.

Weisberg AS, Maruri-Avidal L, Bisht H, Hansen BT, Schwartz CL, Fischer ER, Meng X, Xiang Y, Moss B.

Proc Natl Acad Sci U S A. 2017 Dec 19;114(51):E11001-E11009. doi: 10.1073/pnas.1716255114. Epub 2017 Dec 4.

26.
27.

HIV-1 gp120 and Modified Vaccinia Virus Ankara (MVA) gp140 Boost Immunogens Increase Immunogenicity of a DNA/MVA HIV-1 Vaccine.

Shen X, Basu R, Sawant S, Beaumont D, Kwa SF, LaBranche C, Seaton KE, Yates NL, Montefiori DC, Ferrari G, Wyatt LS, Moss B, Alam SM, Haynes BF, Tomaras GD, Robinson HL.

J Virol. 2017 Nov 30;91(24). pii: e01077-17. doi: 10.1128/JVI.01077-17. Print 2017 Dec 15.

28.

Safety and Immunogenicity of PENNVAX-G DNA Prime Administered by Biojector 2000 or CELLECTRA Electroporation Device With Modified Vaccinia Ankara-CMDR Boost.

Ake JA, Schuetz A, Pegu P, Wieczorek L, Eller MA, Kibuuka H, Sawe F, Maboko L, Polonis V, Karasavva N, Weiner D, Sekiziyivu A, Kosgei J, Missanga M, Kroidl A, Mann P, Ratto-Kim S, Anne Eller L, Earl P, Moss B, Dorsey-Spitz J, Milazzo M, Laissa Ouedraogo G, Rizvi F, Yan J, Khan AS, Peel S, Sardesai NY, Michael NL, Ngauy V, Marovich M, Robb ML.

J Infect Dis. 2017 Nov 27;216(9):1080-1090. doi: 10.1093/infdis/jix456.

29.

Droplet digital PCR for rapid enumeration of viral genomes and particles from cells and animals infected with orthopoxviruses.

Americo JL, Earl PL, Moss B.

Virology. 2017 Nov;511:19-22. doi: 10.1016/j.virol.2017.08.005. Epub 2017 Aug 10.

30.

Wellness and the Role of Comorbidities in Multiple Sclerosis.

Moss BP, Rensel MR, Hersh CM.

Neurotherapeutics. 2017 Oct;14(4):999-1017. doi: 10.1007/s13311-017-0563-6. Review.

31.

Preparation of Cell Cultures and Vaccinia Virus Stocks.

Cotter CA, Earl PL, Wyatt LS, Moss B.

Curr Protoc Protein Sci. 2017 Aug 1;89:5.12.1-5.12.18. doi: 10.1002/cpps.34.

PMID:
28762495
32.

Generation of Recombinant Vaccinia Viruses.

Wyatt LS, Earl PL, Moss B.

Curr Protoc Protein Sci. 2017 Aug 1;89:5.13.1-5.13.18. doi: 10.1002/cpps.33.

33.

Neurosarcoidosis.

Culver DA, Ribeiro Neto ML, Moss BP, Willis MA.

Semin Respir Crit Care Med. 2017 Aug;38(4):499-513. doi: 10.1055/s-0037-1604165. Epub 2017 Jul 27. Review. No abstract available.

PMID:
28750463
34.

Insufficient Innate Immunity Contributes to the Susceptibility of the Castaneous Mouse to Orthopoxvirus Infection.

Earl PL, Americo JL, Moss B.

J Virol. 2017 Sep 12;91(19). pii: e01042-17. doi: 10.1128/JVI.01042-17. Print 2017 Oct 1.

35.

Identification of Vaccinia Virus Replisome and Transcriptome Proteins by Isolation of Proteins on Nascent DNA Coupled with Mass Spectrometry.

Senkevich TG, Katsafanas GC, Weisberg A, Olano LR, Moss B.

J Virol. 2017 Sep 12;91(19). pii: e01015-17. doi: 10.1128/JVI.01015-17. Print 2017 Oct 1.

36.

HIVIS-DNA or HIVISopt-DNA priming followed by CMDR vaccinia-based boosts induce both humoral and cellular murine immune responses to HIV.

Hinkula J, Petkov S, Ljungberg K, Hallengärd D, Bråve A, Isaguliants M, Falkeborn T, Sharma S, Liakina V, Robb M, Eller M, Moss B, Biberfeld G, Sandström E, Nilsson C, Markland K, Blomberg P, Wahren B.

Heliyon. 2017 Jun 29;3(6):e00339. doi: 10.1016/j.heliyon.2017.e00339. eCollection 2017 Jun.

37.

Supporting people with aphasia to 'settle into a new way to be': speech and language therapists' views on providing psychosocial support.

Northcott S, Simpson A, Moss B, Ahmed N, Hilari K.

Int J Lang Commun Disord. 2018 Jan;53(1):16-29. doi: 10.1111/1460-6984.12323. Epub 2017 Jun 16.

PMID:
28621012
38.

Comparing photoelectrochemical water oxidation, recombination kinetics and charge trapping in the three polymorphs of TiO2.

Moss B, Lim KK, Beltram A, Moniz S, Tang J, Fornasiero P, Barnes P, Durrant J, Kafizas A.

Sci Rep. 2017 Jun 7;7(1):2938. doi: 10.1038/s41598-017-03065-5.

39.

Novel Nonreplicating Vaccinia Virus Vector Enhances Expression of Heterologous Genes and Suppresses Synthesis of Endogenous Viral Proteins.

Wyatt LS, Xiao W, Americo JL, Earl PL, Moss B.

MBio. 2017 Jun 6;8(3). pii: e00790-17. doi: 10.1128/mBio.00790-17.

40.
41.

Comparison of nomograms predicting lymph node invasion in patients undergoing radical prostatectomy for prostate cancer.

Nason GJ, O'Connor EM, MacMahon D, Moss B, Considine SW, Cahill A, O'Rourke C, O'Brien FM.

Ir J Med Sci. 2018 Feb;187(1):33-37. doi: 10.1007/s11845-017-1626-8. Epub 2017 May 6.

PMID:
28478609
42.

Triad of human cellular proteins, IRF2, FAM111A, and RFC3, restrict replication of orthopoxvirus SPI-1 host-range mutants.

Panda D, Fernandez DJ, Lal M, Buehler E, Moss B.

Proc Natl Acad Sci U S A. 2017 Apr 4;114(14):3720-3725. doi: 10.1073/pnas.1700678114. Epub 2017 Mar 20.

43.

Investigating Viruses during the Transformation of Molecular Biology.

Moss B.

J Biol Chem. 2017 Mar 10;292(10):3958-3969. doi: 10.1074/jbc.X117.778712. Epub 2017 Jan 30.

44.

Preparation of Cell Cultures and Vaccinia Virus Stocks.

Cotter CA, Earl PL, Wyatt LS, Moss B.

Curr Protoc Mol Biol. 2017 Jan 5;117:16.16.1-16.16.18. doi: 10.1002/cpmb.33.

PMID:
28060410
45.

Generation of Recombinant Vaccinia Viruses.

Wyatt LS, Earl PL, Moss B.

Curr Protoc Mol Biol. 2017 Jan 5;117:16.17.1-16.17.18. doi: 10.1002/cpmb.32.

PMID:
28060405
46.

Three-Year Durability of Immune Responses Induced by HIV-DNA and HIV-Modified Vaccinia Virus Ankara and Effect of a Late HIV-Modified Vaccinia Virus Ankara Boost in Tanzanian Volunteers.

Joachim A, Munseri PJ, Nilsson C, Bakari M, Aboud S, Lyamuya EF, Tecleab T, Liakina V, Scarlatti G, Robb ML, Earl PL, Moss B, Wahren B, Mhalu F, Ferrari G, Sandstrom E, Biberfeld G.

AIDS Res Hum Retroviruses. 2017 Aug;33(8):880-888. doi: 10.1089/AID.2016.0251. Epub 2017 Jan 27.

47.

A homolog of the variola virus B22 membrane protein contributes to ectromelia virus pathogenicity in the mouse footpad model.

Reynolds SE, Earl PL, Minai M, Moore I, Moss B.

Virology. 2017 Jan 15;501:107-114. doi: 10.1016/j.virol.2016.11.010. Epub 2016 Nov 26.

48.

Evaluating Coincident Relationships Between Obesity Incidence and Normal Weight Incidence From Birth Through Kindergarten for US Children.

Yeaton WH, Shah MK, Moss BG.

Am J Health Promot. 2018 Jan;32(1):177-187. doi: 10.1177/0890117116676545. Epub 2016 Nov 22.

PMID:
27879295
49.

Safety of monoclonal antibodies for the treatment of multiple sclerosis.

McGinley MP, Moss BP, Cohen JA.

Expert Opin Drug Saf. 2017 Jan;16(1):89-100. Epub 2016 Oct 31. Review.

PMID:
27756172
50.

High Doses of GM-CSF Inhibit Antibody Responses in Rectal Secretions and Diminish Modified Vaccinia Ankara/Simian Immunodeficiency Virus Vaccine Protection in TRIM5α-Restrictive Macaques.

Kannanganat S, Wyatt LS, Gangadhara S, Chamcha V, Chea LS, Kozlowski PA, LaBranche CC, Chennareddi L, Lawson B, Reddy PB, Styles TM, Vanderford TH, Montefiori DC, Moss B, Robinson HL, Amara RR.

J Immunol. 2016 Nov 1;197(9):3586-3596. Epub 2016 Sep 28.

Supplemental Content

Support Center